Living with epilepsy can be challenging, and even scary at times, but it doesn’t have to stop you from pursuing your dreams. With the help…
Host a 2017 CURE Seminar At Your Institution CURE is now accepting applications for the 2017 Frontiers in Research Seminar Series! Approximately 10 seminars will be…
CURE is Proud to Sponsor the Gordon Research Seminar and Gordon Research Conference on Mechanisms of Epilepsy & Neuronal Synchronization GRS August 20-21, 2016 | GRC August 21-26,…
– Everolimus is the first adjunctive therapy shown in a prospective randomized Phase III study to achieve clinically significant seizure control in TSC patients(1) –…